Back to search

A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in a Real-World Setting

Carcinoma, Non-Small-Cell Lung
Clinicaltrials.gov:
Other:
#61186372NSC4014
Interested in this trial?
Subscribe or share this trial
Countries:
  • Austria,
  • Czechia,
  • Germany,
  • Israel,
  • Italy,
  • Spain,
  • United Kingdom
Loading...
Enrolling
Palermo, Italy, 90146
Enrolling
Olbia, Italy, 07026
Enrolling
Milan, Italy, 20162
Enrolling
Tel Aviv, Israel, 6971028
Enrolling
Bochum, Germany, 44791
Enrolling
Lecce, Italy, 73100
Enrolling
Catanzaro, Italy, 88100
Enrolling
Novara, Italy, 28100
Enrolling
Palermo, Italy, 90127
Enrolling
Sassari, Italy, 07100
Enrolling
Ulm, Germany, 89081
Enrolling
Eastbourne, United Kingdom, BN21 2UD
Enrolling
Milan, Italy, 20141
Enrolling
Bielefeld, Germany, 33611
Enrolling
Hamburg, Germany, 20249
Enrolling
Prague, Czechia, 140 59
Enrolling
Brno, Czechia, 625 00
Enrolling
Hradec Králové, Czechia, 500 05
Enrolling
Olomouc, Czechia, 77900
Enrolling
Naples, Italy, 80131
Enrolling
Cologne, Germany, 50677
Enrolling
Córdoba, Spain, 14004
Enrolling
Valladolid, Spain, 47003
Enrolling
Lugo, Spain, 27003
Enrolling
Seville, Spain, 41013
Enrolling
Milan, Italy, 20133
Enrolling
Candiolo, Italy, 10060
Enrolling
Essen, Germany, 45136
Enrolling
Chemnitz, Germany, 09113
Enrolling
Klagenfurt, Austria, 9020
Enrolling
Konstanz, Germany, 78464
Enrolling
Hanover, Germany, 30449
Enrolling
Hemer, Germany, 58675
Enrolling
Stolberg, Germany, 52222
Enrolling
Aschaffenburg, Germany, 63739
Enrolling
Heath Town, United Kingdom, WV10 0QP
Enrolling
Bari, Italy, 70124
Enrolling
Hanover, Germany, 30161
Enrolling
Genova, Italy, 16132
Enrolling
Avellino, Italy, 83100
Enrolling
Torrette-Ancona, Italy, 60126
Enrolling
Catania, Italy, 95123
Enrolling
Petah Tikva, Israel, 4941492
Enrolling
London, United Kingdom, SW3 6JJ
Enrolling
Sutton, United Kingdom, SM2 5PT
Enrolling
Milan, Italy, 20132
Enrolling
Ramat Gan, Israel, 5262000
Enrolling
Manchester, United Kingdom, M20 4BX
#
More than 50 sites in this region
#
More than 10 sites in this region
#
Less than 10 sites in this region
Map pin icon representing individual study sites
Individual sites
Access detailed information on the trial:
© Johnson & Johnson and its affiliates 2026
J&J Clinical Trials